The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Research Director, CNRS. With an interest in understanding the mechanisms that contribute to the silencing or activation of mammalian genes.
Maura Pellei is Associate Professor of General and Inorganic Chemistry at the University of Camerino. In 1993 she graduated in biological science at the University of l′Aquila. She obtained her degree in chemistry in 2003 and her Ph.D. in chemical sciences in 2010 at the University of Camerino. Her research interests are in coordination
chemistry, bioinorganic systems, and metal-based drugs.
With a B.Sc. in Mathematics and Applied Mathematics from the University of Shantou, China (2003), a M.Sc. in Data Analysis, Network and Nonlinear Dynamical System from the University of York, UK (2004), and a Ph.D. in Statistics from the University of Leeds, UK (2008), Dr. Luo has gained extensive knowledge& experience in applied mathematics and statistics, computer simulations & forecasting, dynamic system and high-dimensional data analysis, to study disease dispersal and mitigation on a multinational scale. He has worked several years as biostatistician at The Food and Environmental Research Agency (UK) before beginning research in Florida (2011) as collaborated research scholar in NCSU and visiting scientist USDA. He played a key role in a wide range of multidisciplinary projects including, but not limited to, risk-based survey of HLB/ACP in FL, CA, TX and AZ, Plum Pox Virus (PPV) survey in NY and CA, Census travel modelling, agent-based disease simulation, GIS disease mapping and Aerial image processing.
Joselito P. Quirino graduated BSc in Industrial Pharmacy from the University of the Philippines Manila in 1992. He finished his MSc/PhD in Analytical Chemistry with Prof. Shigeru Terabe at the Himeji Institute of Technology Japan in 1998/1999. He was then a postdoctoral researcher in Prof. Richard Zare’s laboratory at Stanford University USA until 2001. This was followed by an industrial stint in pharmaceutical companies in California USA until 2007. He went back to academia at the ACROSS in the University of Tasmania where he is currently an Associate Professor. He has been awarded an Australian Research Council Future Fellowship and Japanese Society for the Promotion of Science Fellowships.
Dieter Deforce PharmD, PhD, head of the Lab for Pharmaceutical Biotechnology at the Faculty of Pharmaceutical Sciences at the University of Gent, Belgium. He is chair of the Belgian Medicines Committee, he is member of the Scientific Advise Working Party of the EMA. He is a partner in NXT-GNT, a research consortium providing the research community next generation DNA-sequencing. He is also a partner in the Bioinformatics Institute Ghent From Nucleotides to Networks (BIG N2N) of the University Ghent. He is member of the board of directors of the VIB.
Research focuses around applying proteomics and genomics platforms (including Next Generation Sequencing) in the field of stem cell development, prenatal genetic diagnosis, (auto-)immunity and forensics.
Associate Professor at Rutgers-New Jersey Medical School, Editor of American Journal of Medical and Biological Research, Dataset Papers in Biology, Frontiers in Physiology, Journal of Cardiovascular Disease Research, PLOS One, World Journal Of Hypertension, and World Journal of Cardiology.
Dr. Luis Pacheco is currently an Associate Professor of Biotechnology (Molecular Biology) at the Universidade Federal da Bahia (UFBA), in Salvador-BA, Brazil. During 2019, he has also been working as a Visiting Researcher at the Brigham and Women’s Hospital / Harvard Medical School, Boston-MA, USA. He received his 2010 PhD in Biochemistry and Molecular Biology from a leading university in Brazil, the Universidade Federal de Minas Gerais (UFMG), with an international split-site scholarship period (2008-2009) at the University of Warwick, in the United Kingdom. His research is focused on using functional genomics and synthetic biology approaches for development of novel genetic tools with broad applications in biotechnology, particularly in the fields of diagnostics of infectious diseases and therapeutics of inflammatory diseases.
Dr Helen Parkinson head of Molecular Archival Resources at EMBL-EBI and leads the Samples, Phenotypes and Ontologies team, delivering databases, data integration tools and ontologies for biomedicine. She is also Interim Team Leader for the Variation Archive team. Trained as a geneticist, Helen's research focused on Drosophila biology, behaviour, molecular biology and medical genetics. Helen's passion is semantic data integration and providing users with useful data. Her team participates extensively in external collaborations ranging from data analysis and generation projects to infrastructural integration projects such as the ELIXIR initiatives BioMedBridges, CORBEL and EXELERATE. In collaboration with partners in the KOMP2 project and the International Mouse Phenotyping Consortium, Helen's SPOT team manages, analyses, and distributes complex phenotypic data from knockout mouse lines and promotes mouse data integration internationally.They also develop open-source software tools for managing data, developing and integrating ontologies and data, and integrating semantic web technologies.
Prior to joining EMBL-EBI in 2000, Helen was a post-doctoral researcher at the University of Leicester, where she worked on the genetic basis of Primary Pulmonary Hypertension, Hyphophatasia and synteny at human chromosomes 7 and 12. Her PhD thesis examined the temperature compensation of circadian rhythms in Drosophila with Professor Bambos Kyriacou.
Beth Polidoro is an Associate Professor of Environmental Chemistry and Marine Conservation, as well as serving as the Deputy Director for the Center for Biodiversity Outcomes at Arizona State University. Her primary research interests are in risk assessment and applied toxicology within the context of marine and freshwater biodiversity conservation, human health, and sustainable development. Dr. Polidoro has a broad background in the marine, chemical and environmental sciences. Before to coming to Arizona State University, she was a senior research associate with the International Union for the Conservation of Nature (IUCN), where she worked with scientists around the globe to quantify the impacts of anthropogenic threats on more than 20,000 marine species, for inclusion on the IUCN Red List of Threatened Species. She currently works on various marine and freshwater conservation initiatives and both ecological and human health risk assessments in the United States, Latin America, Africa and Oceania.
I am a plant ecologist and my interests include forest structure and dynamics, species diversity, plant traits and relationships with environmental gradients. I am an Ecology professor and researcher at the Federal University of Amazonas (UFAM) and an associate researcher at the National Institute for Amazonia Research (INPA) in Manaus, Brazil.
Professor of Food Engineering, School of Food Engineering, University of Campinas, São Paulo, Brazil. My main research areas are microencapsulation, membrane processes and edible coatings
I am a Professor at the University of Santiago de Compostela (Galicia, Spain). During the last few years I have been investigating in various fields of biomedical research, such as the analysis of genetic susceptibility to complex and common diseases (breast cancer, schizophrenia, autism, etc.), rare diseases (Wilson's disease, congenital ichthyosis, mitochondriopathies, etc.), bioinformatics / biostatistics (regarding HapMap, 1000 Genomes, statistical procedures in epidemiology and genetics, etc.), molecular / archeo-genetic anthropology, and forensic genetics (population sub-structure, interpretation (statistics) of the test Medical-legal research haplotype markers, etc).
I am the head of a consolidated research group, GenPoB (Population Genetics in Biomedicine), based at the Health Research Institute (IDIS) of Santiago de Compostela (Galicia, Spain), that is in turn integrated into the Genetics and Systems Biology group.
For more than a decade I have been heavily involved in a variety of projects related to genomics and other fields of -omic ’sciences (e.g. transcriptomic, epigenomic), in complex pediatric diseases, infectology and vaccinomics.